↓ Skip to main content

Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression

Overview of attention for article published in Journal of Hematology & Oncology, April 2012
Altmetric Badge

Citations

dimensions_citation
110 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression
Published in
Journal of Hematology & Oncology, April 2012
DOI 10.1186/1756-8722-5-15
Pubmed ID
Authors

David Z Chang, Ying Ma, Baoan Ji, Yan Liu, Patrick Hwu, James L Abbruzzese, Craig Logsdon, Huamin Wang

Abstract

Cell division cycle 20 (CDC20) homolog is an anaphase-promoting complex activator that is essential for cell division, but whether its expression in pancreatic ductal adenocarcinoma (PDAC) is significant is unknown. In this retrospective study, we determined whether aberrant CDC20 expression can be used as a biomarker in pancreatic ductal adenocarcinoma (PDAC) tumorigenesis and whether its expression reflects clinical progression.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
France 2 3%
Unknown 63 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 19%
Student > Ph. D. Student 11 16%
Student > Bachelor 8 12%
Student > Master 8 12%
Student > Postgraduate 4 6%
Other 8 12%
Unknown 15 22%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 19 28%
Medicine and Dentistry 15 22%
Agricultural and Biological Sciences 9 13%
Computer Science 2 3%
Mathematics 1 1%
Other 3 4%
Unknown 18 27%